Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Centre Oscar Lambret
Mayo Clinic
University of California, Irvine
TILT Biotherapeutics Ltd.
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Ossium Health, Inc.
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Essen Biotech
Dana-Farber Cancer Institute
Ohio State University Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
City of Hope Medical Center
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
University Health Network, Toronto
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
Hadassah Medical Organization
Hadassah Medical Organization
Valo Therapeutics Oy
Herlev Hospital
Herlev Hospital
University of Pittsburgh
University of Pennsylvania
City of Hope Medical Center
Thomas Jefferson University
City of Hope Medical Center